Investigation of the use of recombinant BCG, expressing the major capsid protein (LI) of human papillomavirus type 16, as a candidate vaccine for cervical cancer

Simple item page
dc.contributor.advisorWilliamson, Anna-Liseen_ZA
dc.contributor.authorMacLean, James Malcolmen_ZA
dc.date.accessioned2014-07-28T08:21:39Z
dc.date.available2014-07-28T08:21:39Z
dc.date.issued2005en_ZA
dc.description.abstractIncludes bibliographical references (leaves 214-236).en_ZA
dc.identifier.apacitationMacLean, J. M. (2005). <i>Investigation of the use of recombinant BCG, expressing the major capsid protein (LI) of human papillomavirus type 16, as a candidate vaccine for cervical cancer</i>. (Thesis). University of Cape Town ,Faculty of Health Sciences ,Division of Virology. Retrieved from http://hdl.handle.net/11427/2730en_ZA
dc.identifier.chicagocitationMacLean, James Malcolm. <i>"Investigation of the use of recombinant BCG, expressing the major capsid protein (LI) of human papillomavirus type 16, as a candidate vaccine for cervical cancer."</i> Thesis., University of Cape Town ,Faculty of Health Sciences ,Division of Virology, 2005. http://hdl.handle.net/11427/2730en_ZA
dc.identifier.citationMacLean, J. 2005. Investigation of the use of recombinant BCG, expressing the major capsid protein (LI) of human papillomavirus type 16, as a candidate vaccine for cervical cancer. University of Cape Town.en_ZA
dc.identifier.ris TY - Thesis / Dissertation AU - MacLean, James Malcolm AB - Includes bibliographical references (leaves 214-236). DA - 2005 DB - OpenUCT DP - University of Cape Town LK - https://open.uct.ac.za PB - University of Cape Town PY - 2005 T1 - Investigation of the use of recombinant BCG, expressing the major capsid protein (LI) of human papillomavirus type 16, as a candidate vaccine for cervical cancer TI - Investigation of the use of recombinant BCG, expressing the major capsid protein (LI) of human papillomavirus type 16, as a candidate vaccine for cervical cancer UR - http://hdl.handle.net/11427/2730 ER - en_ZA
dc.identifier.urihttp://hdl.handle.net/11427/2730
dc.identifier.vancouvercitationMacLean JM. Investigation of the use of recombinant BCG, expressing the major capsid protein (LI) of human papillomavirus type 16, as a candidate vaccine for cervical cancer. [Thesis]. University of Cape Town ,Faculty of Health Sciences ,Division of Virology, 2005 [cited yyyy month dd]. Available from: http://hdl.handle.net/11427/2730en_ZA
dc.language.isoengen_ZA
dc.publisher.departmentDivision of Virologyen_ZA
dc.publisher.facultyFaculty of Health Sciencesen_ZA
dc.publisher.institutionUniversity of Cape Town
dc.subject.otherMedical Virologyen_ZA
dc.titleInvestigation of the use of recombinant BCG, expressing the major capsid protein (LI) of human papillomavirus type 16, as a candidate vaccine for cervical canceren_ZA
dc.typeDoctoral Thesis
dc.type.qualificationlevelDoctoral
dc.type.qualificationnamePhDen_ZA
uct.type.filetypeText
uct.type.filetypeImage
uct.type.publicationResearchen_ZA
uct.type.resourceThesisen_ZA
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
thesis_hsf_2005_mcclean_jm.pdf
Size:
13.01 MB
Format:
Adobe Portable Document Format
Description:
Download
Collections
PhD / Doctoral